BCP is often categorized as a cannabinoid, not a terpene, because of how it binds to CB2 cannabinoid receptors. It is not only found in several legal herbs and spices (pepper corns, hops, rosemary and cloves) but is even an FDA-approved food additive. For this reason, some sources label BCP the “first dietary cannabinoid.” BCP can be used as a gastroprotective (treats ulcers), has potential to fight cancer side effects, such as wound healing and may protect the body from disease. It can potentially be used to treat several inflammatory disorders, including arthritis and multiple sclerosis. BCP also be helpful for those suffering from atherosclerosis and osteoporosis and may even increase bone mass and block pain receptors, all while avoiding any interference with the nervous system.

Beta-caryophyllene enhances wound healing through multiple routes

Beta-Caryophyllene in Glioblastoma Therapy

β-Caryophyllene Inhibits Cell Proliferation through a Direct Modulation of CB2 Receptors in Glioblastoma Cells

Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception

β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner